Cargando…
Early passaging of mesenchymal stem cells does not instigate significant modifications in their immunological behavior
BACKGROUND: Bone marrow-derived allogeneic mesenchymal stem cells (MSCs) from young healthy donors are immunoprivileged and their clinical application for regenerative medicine is under evaluation. However, data from preclinical and initial clinical trials indicate that allogeneic MSCs after transpl...
Autores principales: | Sareen, Niketa, Sequiera, Glen Lester, Chaudhary, Rakesh, Abu-El-Rub, Ejlal, Chowdhury, Subir Roy, Sharma, Vikram, Surendran, Arun, Moudgil, Meenal, Fernyhough, Paul, Ravandi, Amir, Dhingra, Sanjiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930635/ https://www.ncbi.nlm.nih.gov/pubmed/29720263 http://dx.doi.org/10.1186/s13287-018-0867-4 |
Ejemplares similares
-
Hypoxia-induced 26S proteasome dysfunction increases immunogenicity of mesenchymal stem cells
por: Abu-El-Rub, Ejlal, et al.
Publicado: (2019) -
Graphene Oxide-Gold Nanosheets Containing Chitosan Scaffold Improves Ventricular Contractility and Function After Implantation into Infarcted Heart
por: Saravanan, Sekaran, et al.
Publicado: (2018) -
Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats
por: Ammar, Hania Ibrahim, et al.
Publicado: (2015) -
Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases
por: Sequiera, Glen Lester, et al.
Publicado: (2022) -
Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells
por: Abu-El-Rub, Ejlal, et al.
Publicado: (2020)